JP2018509912A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509912A5
JP2018509912A5 JP2017549044A JP2017549044A JP2018509912A5 JP 2018509912 A5 JP2018509912 A5 JP 2018509912A5 JP 2017549044 A JP2017549044 A JP 2017549044A JP 2017549044 A JP2017549044 A JP 2017549044A JP 2018509912 A5 JP2018509912 A5 JP 2018509912A5
Authority
JP
Japan
Prior art keywords
strand
sequence
mir
seq
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017549044A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/022645 external-priority patent/WO2016149370A1/en
Publication of JP2018509912A publication Critical patent/JP2018509912A/ja
Publication of JP2018509912A5 publication Critical patent/JP2018509912A5/ja
Pending legal-status Critical Current

Links

JP2017549044A 2015-03-16 2016-03-16 感覚の状態を処置することにおけるmiRNA模倣物およびその使用 Pending JP2018509912A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562133590P 2015-03-16 2015-03-16
US62/133,590 2015-03-16
PCT/US2016/022645 WO2016149370A1 (en) 2015-03-16 2016-03-16 Mirna mimetics and their use in treating sensory conditions

Publications (2)

Publication Number Publication Date
JP2018509912A JP2018509912A (ja) 2018-04-12
JP2018509912A5 true JP2018509912A5 (https=) 2019-04-25

Family

ID=56919428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017549044A Pending JP2018509912A (ja) 2015-03-16 2016-03-16 感覚の状態を処置することにおけるmiRNA模倣物およびその使用

Country Status (7)

Country Link
US (1) US20180080023A1 (https=)
EP (1) EP3271464A4 (https=)
JP (1) JP2018509912A (https=)
CN (1) CN107532181A (https=)
AU (1) AU2016233311A1 (https=)
CA (1) CA2979825A1 (https=)
WO (1) WO2016149370A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12083143B2 (en) 2018-04-06 2024-09-10 University Of Massachusetts MLK-regulated microRNAs in angiogenesis and tumor development
CA3115810A1 (en) 2018-10-11 2020-04-16 Decibel Therapeutics, Inc. Aav1 vectors and uses thereof for treatment of otic indications
CN110013486B (zh) * 2019-03-27 2021-08-17 浙江大学 mmu-miR-183-5p在制备抑制胚胎着床的药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683036B2 (en) * 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
JP2010537640A (ja) * 2007-08-27 2010-12-09 ボストン バイオメディカル, インコーポレイテッド マイクロrna模倣剤または阻害剤としての非対称性rna二重鎖の組成物
US8258111B2 (en) * 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
US8455454B2 (en) * 2008-08-27 2013-06-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services miR 204, miR 211, their anti-miRs, and therapeutic uses of same
WO2011028550A1 (en) * 2009-08-24 2011-03-10 Merck Sharp & Dohme Corp. Segmented micro rna mimetics
US9416369B2 (en) * 2012-12-18 2016-08-16 University Of Washington Through Its Center For Commercialization Methods and compositions to modulate RNA processing
US20150051267A1 (en) * 2013-08-16 2015-02-19 Purdue Research Foundation BICISTRONIC GENE TRANSFER TOOLS FOR DELIVERY OF miRNAS AND PROTEIN CODING SEQUENCES
EP3049522A2 (en) * 2013-09-26 2016-08-03 Friedrich Miescher Institute for Biomedical Research Tools and methods using mirna 182, 96 and/or 183 for treating pathologies
GB201400598D0 (en) * 2014-01-14 2014-03-05 Univ Glasgow Materials and methods for modulation of tendon healing

Similar Documents

Publication Publication Date Title
US12472239B2 (en) Guide RNA for repairing a mutant human titin gene using CRISPR technology
US11920132B2 (en) Oligonucleotide therapy for Leber congenital amaurosis
US11001844B2 (en) CRISPR/Cas-related methods and compositions for treating herpes simplex virus
EP4123024B1 (en) Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)
US20210054405A1 (en) Closed-ended dna (cedna) vectors for insertion of transgenes at genomic safe harbors (gsh) in humans and murine genomes
US12442003B2 (en) Trans-splicing molecules
CN114450031A (zh) 靶向rna的敲低和替代组合物及使用方法
WO2015153791A1 (en) Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2)
CN114040974A (zh) 用于高效rna反式剪接的三螺旋终止子
JP2018509912A5 (https=)
CA3239289A1 (en) Functional aav capsids for intravitreal administration
US20180080023A1 (en) Mirna mimetics and their use in treating sensory conditions
US20240325454A1 (en) Genomic editing of rbm20 mutations
EA043766B1 (ru) Средства и способы лечения миопатий, связанных с титином, и других титинопатий